Cas:68384-89-4 1-methylpyrrole-2,4-dicarboxylic acid manufacturer & supplier

We serve Chemical Name:1-methylpyrrole-2,4-dicarboxylic acid CAS:68384-89-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-methylpyrrole-2,4-dicarboxylic acid

Chemical Name:1-methylpyrrole-2,4-dicarboxylic acid
CAS.NO:68384-89-4
Synonyms:1H-Pyrrole-2,4-dicarboxylic acid,1-methyl
Molecular Formula:C7H7NO4
Molecular Weight:169.13500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:79.53000
Exact Mass:169.03800
LogP:0.42150

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1H-Pyrrole-2,4-dicarboxylic acid,1-methyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Pyrrole-2,4-dicarboxylic acid,1-methyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Pyrrole-2,4-dicarboxylic acid,1-methyl Use and application,1H-Pyrrole-2,4-dicarboxylic acid,1-methyl technical grade,usp/ep/jp grade.


Related News: INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. 1-methylpyrrole-2,4-dicarboxylic acid manufacturer It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing. 1-methylpyrrole-2,4-dicarboxylic acid supplier In October 2020, the Trump administration ordered $375 million worth of Lilly’s COVID-19 antibody therapy bamlanivimab, which is manufactured at the Branchburg plant. 1-methylpyrrole-2,4-dicarboxylic acid vendor It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing. 1-methylpyrrole-2,4-dicarboxylic acid factory It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.